Pharma News, Research & Solutions

GSK announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for a new four-dose vial presentation of its Synflorix pneumococcal vaccine.

Johnson & Johnson has released its 2016 Health for Humanity Reportsharing progress on environmental, social and governance measures, which advance the Company’s mission to profoundly improve the course of health for humanity. Our Johnson & Johnson Health for Humanity Report (formerly named Citizenship & Sustainability Report) also includes a scorecard for the Johnson & Johnson Health for Humanity 2020 Goals, which were launched in June 2016 as a new set of commitments.

Today, Abbott released its 2016 Global Sustainability Report, reinforcing its dedication to helping people live fuller, healthier lives around the world. The report details the company's global sustainability efforts and results, including its work to protect the environment, as more than 130 environmental projects in 2016 alone improved waste, water and energy efficiencies globally.

Novartis reaches agreement with Pakistan to supply medicines that address the rapid rise of chronic illness among poor people in the world's sixth most populous nation. Novartis Access medicines will be made available to the poorest population in Pakistan through hospitals under the Prime Minister’s National Health Insurance Program.

For the ninth consecutive year, Bristol-Myers Squibb ranks in the top 20 of the 100 Best Corporate Citizens, a leading benchmark for socially responsible investors and other stakeholders published by Corporate Responsibility magazine.

What could changes in health care policy mean for the work of foundations focused on health?

Gilead Sciences, Inc. today announced that it issued its Year in Review 2016, a combination of the company’s Annual Report and Corporate Social Responsibility report. This report provides an in-depth look into Gilead’s commitment to develop and deliver innovative therapies that change lives.

NORTHBROOK, Ill., April 27, 2017 /3BL Media/ -- Astellas today announced that Astellas Americas President Jim Robinson will participate in a panel entitled "Getting Our Health Priorities in Order: Prevention, Research, and Treatment" from 8 – 9:15 a.m. PT Monday, May 1 at the 20th Annual Milken Institute Global Conference in Los Angeles. The conference convenes more than 3,500 attendees from 50 countries – all senior decision-makers in their fields — to tackle the world's most stubborn challenges.

Merck KGaA, Darmstadt, Germany has published its eighth Corporate Responsibility Report, covering the years 2015 and 2016. It is available online at www.emdgroup.com/cr-report.

PatientsLikeMe and Shire plc have announced a new collaboration that will support the development of a patient-centered, real world health learning system that expands understanding of patient health and disease.